Deliver to United Kingdom
0

HPLC column NUCLEODUR ® Sphinx RP, 3 µm, 100 mm, 4 mm

£ 788.54*

*Prices plus VAT plus shipping costs

£ 946.25*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® Sphinx RP, 3 µm, 100 mm, 4 mm

Order number: 354Y.1

Part number: AC100008743

In Stock

Price Breakdown

1

6

24

Manufactured to meet research and production requirements, this HPLC column, specifically the Nucleodur Sphinx RP, boasts a unique selectivity due to its bifunctional RP phase made from high purity silica gel, featuring a balanced ratio of propylphenyl and C18 ligands. With a particle size of 3 μm, it offers a pore size of 110 Å and a specific surface area of 340 m²/g, as per BET. This column is suitable for a wide range of applications including quinolone antibiotics, substituted aromatics, sulfonamides, xanthines, and those requiring additional π-π interactions. It is designed to operate at temperatures up to 60°C and withstand pressures of up to 600 bar. Its recommended eluent is acetonitrile-water mixture

  • Category: Separation columns for HPLC
  • Pressure stability: 600 bar
  • Specific surface according to BET: 340 m²/g
  • Column volume: 1.25 ml
  • Separation principle: Reversed phase (RP)
  • Interactions / retention mechanism: π-π and hydrophobic
  • USP listing: L1 L11
  • Column type: HPLC column
  • Particle size: 3 µm
  • L x Ø internal (column): 100 x 4 mm
  • Particle type: Fully porous particles (FPP)
  • Eluent in column: Acetonitrile - Water
  • pH stability: 1,0-10,0
  • Column shape: Analytical separation column
  • Pore volume: 0.9 ml/g
  • Temperature stability: 60 ° C
  • Surface chemistry: Bifunctional RP phase, balanced ratio of propylphenyl and C 18 ligands
  • Pore size: 110 Å
  • Endcapped: yes
  • Phase: Sphinx RP
  • Recommended application(s): Quinolone antibiotics Suitable for LC-MS Substituted aromatics Sulfonamides Xanthines Additional π-π interactions
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.